Denmark may boast a GDP of approximately 430 billion dollars, but within its borders lies a pharmaceutical giant that dwarfs the nation’s economic output. Novo Nordisk, a Danish company specializing in healthcare, carries a market cap exceeding 604 billion dollars, surpassing even luxury powerhouse LVMH. This year alone, Novo Nordisk has soared past Tesla in...
